Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,330
-10 (-0.07%)
Last updated: Apr 17, 2025
Daewon Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 598,162 | 526,952 | 478,885 | 354,176 | 308,501 | Upgrade
|
Other Revenue | -0 | -0 | -0 | -0 | 0 | Upgrade
|
Revenue | 598,162 | 526,952 | 478,885 | 354,176 | 308,501 | Upgrade
|
Revenue Growth (YoY) | 13.51% | 10.04% | 35.21% | 14.81% | -2.93% | Upgrade
|
Cost of Revenue | 312,188 | 271,808 | 243,038 | 179,630 | 144,354 | Upgrade
|
Gross Profit | 285,974 | 255,144 | 235,847 | 174,546 | 164,147 | Upgrade
|
Selling, General & Admin | 226,957 | 198,507 | 173,719 | 144,585 | 135,522 | Upgrade
|
Research & Development | 21,926 | 18,207 | 12,646 | - | - | Upgrade
|
Other Operating Expenses | 3,242 | 2,951 | 2,320 | 8,009 | 2,080 | Upgrade
|
Operating Expenses | 259,297 | 222,911 | 192,943 | 155,243 | 140,168 | Upgrade
|
Operating Income | 26,677 | 32,233 | 42,904 | 19,303 | 23,979 | Upgrade
|
Interest Expense | -9,306 | -4,614 | -3,683 | -2,078 | -1,182 | Upgrade
|
Interest & Investment Income | 1,664 | 1,416 | 1,259 | 532.2 | 281.72 | Upgrade
|
Earnings From Equity Investments | 996.46 | 509.42 | 860.08 | 382.62 | 517.27 | Upgrade
|
Currency Exchange Gain (Loss) | 156.06 | 121.26 | 219.82 | 71.59 | -91.69 | Upgrade
|
Other Non Operating Income (Expenses) | 1,354 | 672.88 | 23.15 | 906.98 | -1,139 | Upgrade
|
EBT Excluding Unusual Items | 21,541 | 30,338 | 41,583 | 19,119 | 22,365 | Upgrade
|
Gain (Loss) on Sale of Investments | -1,149 | -61.5 | -752.76 | -870.39 | 1,990 | Upgrade
|
Gain (Loss) on Sale of Assets | -312.09 | 149.95 | 45.71 | -0.86 | 2.34 | Upgrade
|
Asset Writedown | -3,921 | -4,597 | -2,154 | -1,111 | -715.77 | Upgrade
|
Pretax Income | 16,159 | 25,830 | 38,722 | 17,136 | 23,642 | Upgrade
|
Income Tax Expense | 6,055 | 2,367 | 8,065 | 10,525 | 6,443 | Upgrade
|
Earnings From Continuing Operations | 10,104 | 23,463 | 30,657 | 6,611 | 17,198 | Upgrade
|
Earnings From Discontinued Operations | -1,059 | - | - | - | - | Upgrade
|
Net Income to Company | 9,045 | 23,463 | 30,657 | 6,611 | 17,198 | Upgrade
|
Minority Interest in Earnings | 5,165 | 453.67 | 1,287 | 378.15 | 441.9 | Upgrade
|
Net Income | 14,210 | 23,917 | 31,944 | 6,989 | 17,640 | Upgrade
|
Net Income to Common | 14,210 | 23,917 | 31,944 | 6,989 | 17,640 | Upgrade
|
Net Income Growth | -40.59% | -25.13% | 357.08% | -60.38% | -35.36% | Upgrade
|
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | Upgrade
|
Shares Outstanding (Diluted) | 22 | 22 | 22 | 21 | 21 | Upgrade
|
Shares Change (YoY) | - | -0.98% | 3.09% | -0.58% | -1.06% | Upgrade
|
EPS (Basic) | 667.43 | 1139.91 | 1509.75 | 329.36 | 826.54 | Upgrade
|
EPS (Diluted) | 656.02 | 1110.44 | 1478.37 | 329.36 | 826.54 | Upgrade
|
EPS Growth | -40.92% | -24.89% | 348.86% | -60.15% | -34.66% | Upgrade
|
Free Cash Flow | -4,829 | 39,446 | 18,405 | 18,309 | 13,605 | Upgrade
|
Free Cash Flow Per Share | -222.96 | 1821.12 | 841.34 | 862.87 | 637.47 | Upgrade
|
Dividend Per Share | - | - | - | 194.175 | 155.340 | Upgrade
|
Dividend Growth | - | - | - | 25.00% | -33.45% | Upgrade
|
Gross Margin | 47.81% | 48.42% | 49.25% | 49.28% | 53.21% | Upgrade
|
Operating Margin | 4.46% | 6.12% | 8.96% | 5.45% | 7.77% | Upgrade
|
Profit Margin | 2.38% | 4.54% | 6.67% | 1.97% | 5.72% | Upgrade
|
Free Cash Flow Margin | -0.81% | 7.49% | 3.84% | 5.17% | 4.41% | Upgrade
|
EBITDA | 46,771 | 49,794 | 62,272 | 37,109 | 39,652 | Upgrade
|
EBITDA Margin | 7.82% | 9.45% | 13.00% | 10.48% | 12.85% | Upgrade
|
D&A For EBITDA | 20,095 | 17,561 | 19,368 | 17,805 | 15,674 | Upgrade
|
EBIT | 26,677 | 32,233 | 42,904 | 19,303 | 23,979 | Upgrade
|
EBIT Margin | 4.46% | 6.12% | 8.96% | 5.45% | 7.77% | Upgrade
|
Effective Tax Rate | 37.47% | 9.16% | 20.83% | 61.42% | 27.25% | Upgrade
|
Advertising Expenses | 33,923 | 29,701 | 27,199 | 26,272 | 23,013 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.